Back to AVXL
Creative Planning AVXL Position History
Anavex Life Sciences Corp. • Healthcare
Quarters held
10
Latest value
$269
Q3 2026
Peak value
$680K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $31K |
| Q3 2025 | $7K |
| Q3 2025 | $680K |
| Q3 2025 | $21K |
| Q4 2025 | $259K |
| Q1 2026 | $333K |
| Q2 2026 | $155K |
| Q2 2026 | $600 |
| Q3 2026 | $84K |
| Q3 2026 | $269 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $269 | 8.0K | — | — |
| Q3 2026 | $84K | 41.8K | — | — |
| Q2 2026 | $600 | 8.0K | — | — |
| Q2 2026 | $155K | 59.8K | — | — |
| Q1 2026 | $333K | 108.3K | — | — |
| Q4 2025 | $259K | 72.7K | — | — |
| Q3 2025 | $21K | 9.5K | — | — |
| Q3 2025 | $680K | 76.4K | — | — |
| Q3 2025 | $7K | 778 | — | — |
| Q3 2025 | $31K | 8.0K | — | — |
Other funds holding AVXL
$45.3M
$40.8M
$39.5M
$37.2M
$34.2M
$33.9M
$29.3M